Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC DB2115 tertahydrochloride | 1366126-19-3 | 99.1% | 704.48 | C32H34Cl4N8O2 | 50MG
SDP

Catalog No. 5000235866
Encompass_Preferred

DB2115 tertahydrochloride is a small-molecule inhibitor of the transcription factor PU.1 (reported IC50: 2.3 nM) provided as the tetrahydrochloride salt for research use. The compound has a molecular weight of 704.48 and formula C32H34Cl4N8O2, and is used in cellular assays investigating tumor cell proliferation and apoptosis in hematologic malignancies.

  • Highly selective PU.1 inhibition with reported IC50 2.3 nM.
  • Suitable for cell proliferation and apoptosis studies.
  • Provided as a tetrahydrochloride salt to aid handling and solubility.
  • High purity, 99.1%.
  • Molecular weight 704.48 and formula C32H34Cl4N8O2.

Catalog No. 50-002-35866 Supplier Medchemexpress LLC Supplier No. HY124676A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DB2115 tertahydrochloride is a small-molecule inhibitor of the transcription factor PU.1 (reported IC50: 2.3 nM) provided as the tetrahydrochloride salt for research use. The compound has a molecular weight of 704.48 and formula C32H34Cl4N8O2, and is used in cellular assays investigating tumor cell proliferation and apoptosis in hematologic malignancies.

  • Highly selective PU.1 inhibition with reported IC50 2.3 nM.
  • Suitable for cell proliferation and apoptosis studies.
  • Provided as a tetrahydrochloride salt to aid handling and solubility.
  • High purity, 99.1%.
  • Molecular weight 704.48 and formula C32H34Cl4N8O2.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.